PATH (Seattle)
PATH is an international nonprofit organization that creates sustainable, culturally relevant solutions enabling communities worldwide to break longstanding cycles of poor health.
Website: http://www.path.org/
April 11
-
Africa: Sanofi and Path Announce the Launch of Large-Scale Production of Semisynthetic Artemisinin Against Malaria [press release]
Sanofi (Euronext: SAN and NYSE: SNY) and PATH's Drug Development program, established through an affiliation with OneWorld Health, today announced the launch of the large-scale... Read more »
January 21
-
Africa: Award Given to Expand Global Malaria Diagnosis and Treatment [press release]
PATH and partners Medical Care Development International, Population Services International, and Save the Children were recently awarded a cooperative agreement with a US$49... Read more »
January 7
-
Africa: Partnership Aims to Accelerate Development of Malaria Vaccines, Innovative Delivery Technologies [press release]
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced a follow-on collaboration to advance malaria vaccine development and new... Read more »
November 12, 2012
-
Africa: It's Best to Use Bednets [guest blog]
Bednets, like seatbelts, are a proven lifesaver, a simple tool that has been shown to sharply reduce deaths from malaria. Yet like seatbelts, bednets can sometimes be a bit of a... Read more »
-
Africa: PATH Director Comments On Malaria Vaccine Results [guest blog]
Dr. David Kaslow is director of the PATH Malaria Vaccine Initiative (MVI). Read more »
-
Africa: PATH's Kent Campbell Honored for Lifetime Achievement in the Fight Against Malaria [press release]
Kent Campbell, PATH's Malaria Control Program director, today received the distinguished Joseph Augustin LePrince Medal in recognition of outstanding work in the field of... Read more »
November 9, 2012
-
Africa: RTS,S Malaria Candidate Vaccine Reduces Malaria By Approximately One-Third in African Infants [press release]
Results from a pivotal, large-scale Phase III trial, published online today in the New England Journal of Medicine, show that the RTS,S malaria vaccine candidate can help protect... Read more »
December 6, 2011
-
Africa: Advancing the Development of a Malaria Transmission-Blocking Vaccine [press release]
Three leaders in malaria vaccine development announced today a collaboration to evaluate a potential vaccine candidate designed to prevent transmission of malaria from mosquitoes... Read more »
October 18, 2011
-
Africa: Vaccine Cuts Malaria Risk by Half for 5-17-month-old Children [press release]
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young... Read more »
June 7, 2011
-
Africa: PATH To Collaborate With GlaxoSmithKline and Crucell in Developing Second-Generation Malaria Vaccine [press release]
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This... Read more »
AllAfrica aggregates and indexes content from over 130 African news organizations, plus more than 200 other sources, who are responsible for their own reporting and views. Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica.
